Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Nov 6, 2017. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-5820-01
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)
- Initial Posting
- Nov 6, 2017
Reason
Other